| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +16.4K | 0.6% | $0.59 | +$9.64K |
| Sells | 2 | -2.63M | 99.4% | $0.55 | -$1.44M |
| Net | -1 | -2.62M | -98.8% | -$1.43M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Nasrat A. Hakim | CEO, President, Director, 10%+ Owner | $8.09M | Mar 29, 2024 | ||
| Douglas Plassche | EVP Operations | $3.52M | -$1.18M | -25.1% | Oct 2, 2025 |
| Elite Pharmaceuticals Inc /Nv/ | EVP Operations | $129K | -$262K | -67% | Aug 22, 2025 |
| Barry Dash | Director | $118K | Nov 22, 2023 | ||
| Jeffrey Whitnell | Director | $116K | Nov 22, 2023 | ||
| S. Caskey | Director | $74.8K | Nov 22, 2023 | ||
| Robert Chen | CFO, Secretary, Treasurer | $27K | May 16, 2022 | ||
| Kirko Kirkov | Chief Commercial Officer | $9.64K | +$9.64K | Jul 10, 2025 | |
| Marc Bregman | CFO, Secretary, Treasurer | $9K | May 17, 2021 | ||
| Mark N. Pellegrino | CFO, Secretary, Treasurer | May 1, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|